We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ASO

News List

n-Lorem Foundation Partners with Argonaut Manufacturing Services contractpharma
February 03, 2022
Will make ASO medicines for patients with nano-rare diseases.
FDA Issues Draft Guidance on Nonclinical Testing of Individualized Antisense Oligonucleotide Drug Products americanpharmaceuticalreview
April 29, 2021
The U.S. Food and Drug Administration has issued the draft guidance “Nonclinical Testing of Individualized Antisense Oligonucleotide (ASO) Drug Products for Severely Debilitating or Life-Threatening Diseases - Guidance for Sponsor-Investigators.”
Aro Biotherapeutics signs licensing agreement worth up to $1.4bn pharmaceutical-technology
January 13, 2020
Aro Biotherapeutics, a biotech firm engaged in the development of protein biologics called Centyrins, has signed a licencing deal that can potentially generate up to $1.4bn for the company.